Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-06	Rachel Altshuler, Ph.D.
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	4U01CA285013-03	Nicholas Hodges, Ph.D.
Kumar, Nagi B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Phase II Clinical trial of GTC in Men on Active Surveillance	5R01CA235032-06	Howard L. Parnes, M.D.
Labaer, Joshua	Arizona State University-Tempe Campus United States	High-throughput immunoproteomics for cancer biomarker discovery	5U2CCA271903-04	Christos Patriotis, Ph.D., M.Sc.
Labaer, Joshua	Arizona State University-Tempe Campus United States	Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck	5R33CA281802-03	Wendy Wang, Ph.D., M.Sc.
Lampe, Paul D.	Fred Hutchinson Cancer Center United States	Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer	5R01CA281801-03	Guillermo Marquez, Ph.D.
Langel, Stephanie N.	Case Western Reserve University United States	Antibody bound bacteria during HPV infection and cervical dysplasia	3R21CA289927-02S1	Goli Samimi, Ph.D., M.P.H.
Langevin, Anne-Marie R.	University Of Texas Hlth Science Center United States	Texas Pediatric NCORP	3UG1CA189855-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Leal, Ana Sofia Mendes	Indiana University Indianapolis United States	Nrf2, immune cells and lung cancer	7R01CA226690-06	Marjorie Perloff, M.D.
Lee, Jeffrey Kuang Zou	Kaiser Foundation Research Institute United States	Vanguard Study Administrative Supplement	3UG1CA287011-02S1	Elyse LeeVan, M.D., M.P.H.
Lee, Richard T	Beckman Research Institute/City Of Hope United States	A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy	1R21CA260447-01A1	Rachel Altshuler, Ph.D.
Lee, Juhun	University Of Pittsburgh At Pittsburgh United States	Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis	5R01CA269540-03	Sidney Fu, M.D.
Lee, Hakho	Massachusetts General Hospital United States	Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array	5U01CA284982-03	Nicholas Hodges, Ph.D.
Lehto, Rebecca H	Henry Ford Health + Michigan State University Health Sciences United States	Support for bereaved friend and family caregivers of cancer patients	1R03CA282943-01A1	Brennan Streck, Ph.D., RN, M.P.H.
Lenburg, Marc Elliott	Boston University Medical Campus United States	The Boston University - UCLA Lung Cancer Biomarker Characterization Center	5U2CCA271898-04	Guillermo Marquez, Ph.D.